Condensed Consolidated Statement of Changes in Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock Common Stock Class T	Common Stock Common Stock Class S	Common Stock Common Stock Class D	Common Stock Common Stock Class I	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit and Cumulative Distributions	Total Stockholders' Equity	Non-Controlling Interests
Balance at Dec. 31, 2020	$ 1,606,416	$ 25	$ 464	$ 28	$ 392	$ 1,819,526		$ (224,198)	$ 1,596,237	$ 10,179
Common stock issued	611,874	2	141	18	121	611,592			611,874
Offering costs	(30,594)					(30,594)			(30,594)
Distribution reinvestments	14,101		4		2	14,095			14,101
Amortization of restricted stock grants	53					53			53
Common stock repurchased	(12,259)		(4)		(1)	(12,254)			(12,259)
Net income (loss) (allocated to redeemable non-controlling interests)	(19,910)							(19,889)	(19,889)	(21)
Distributions to non-controlling interests	(304)									(304)
Distributions declared on common stock (see Note 11)	(30,509)							(30,509)	(30,509)
Allocation to redeemable non-controlling interests	(839)					(839)			(839)
Balance at Mar. 31, 2021	2,138,029	27	605	46	514	2,401,579		(274,596)	2,128,175	9,854
Balance at Dec. 31, 2020	1,606,416	25	464	28	392	1,819,526		(224,198)	1,596,237	10,179
Allocation to redeemable non-controlling interests	(5,556)
Balance at Sep. 30, 2021	4,854,375	40	1,216	188	1,148	5,378,498		(539,203)	4,841,887	12,488
Balance at Mar. 31, 2021	2,138,029	27	605	46	514	2,401,579		(274,596)	2,128,175	9,854
Common stock issued	1,368,383	6	297	45	274	1,367,761			1,368,383
Offering costs	(68,577)					(68,577)			(68,577)
Distribution reinvestments	17,749		5		3	17,741			17,749
Amortization of restricted stock grants	162					162			162
Common stock repurchased	(16,827)		(3)		(5)	(16,819)			(16,827)
Net income (loss) (allocated to redeemable non-controlling interests)	(44,103)							(43,981)	(43,981)	(122)
Distributions to non-controlling interests	(246)									(246)
Distributions declared on common stock (see Note 11)	(45,219)							(45,219)	(45,219)
Allocation to redeemable non-controlling interests	(1,465)					(1,465)			(1,465)
Balance at Jun. 30, 2021	3,347,886	33	904	91	786	3,700,382		(363,796)	3,338,400	9,486
Common stock issued	1,747,984	7	308	97	360	1,747,212			1,747,984
Offering costs	(81,819)					(81,819)			(81,819)
Distribution reinvestments	26,523		6		5	26,512			26,523
Amortization of restricted stock grants	161					161			161
Common stock repurchased	(10,703)		(2)		(3)	(10,698)			(10,703)
Net income (loss) (allocated to redeemable non-controlling interests)	(109,428)							(109,252)	(109,252)	(176)
Contributions from non-controlling interests	3,537									3,537
Distributions to non-controlling interests	(359)									(359)
Distributions declared on common stock (see Note 11)	(66,155)							(66,155)	(66,155)
Allocation to redeemable non-controlling interests	(3,252)					(3,252)			(3,252)
Balance at Sep. 30, 2021	4,854,375	40	1,216	188	1,148	5,378,498		(539,203)	4,841,887	12,488
Balance at Dec. 31, 2021	6,673,718	46	1,544	221	1,636	7,388,885	$ (530)	(757,575)	6,634,227	39,491
Common stock issued	2,067,821	8	346	54	388	2,067,025			2,067,821
Offering costs	(93,736)					(93,736)			(93,736)
Distribution reinvestments	44,740		8	1	7	44,724			44,740
Amortization of restricted stock grants	206					206			206
Common stock repurchased	(47,010)		(11)	(1)	(7)	(46,991)			(47,010)
Net income (loss) (allocated to redeemable non-controlling interests)	25,783							24,860	24,860	923
Contributions from non-controlling interests	1,686									1,686
Distributions to non-controlling interests	(664)									(664)
Distributions declared on common stock (see Note 11)	(112,669)							(112,669)	(112,669)
Other comprehensive loss, net	(4,388)						(4,388)		(4,388)
Allocation to redeemable non-controlling interests	(12,381)					(12,381)			(12,381)
Balance at Mar. 31, 2022	8,543,106	54	1,887	275	2,024	9,347,732	(4,918)	(845,384)	8,501,670	41,436
Balance at Dec. 31, 2021	6,673,718	46	1,544	221	1,636	7,388,885	(530)	(757,575)	6,634,227	39,491
Other comprehensive loss, net	(79,440)
Allocation to redeemable non-controlling interests	(34,086)
Balance at Sep. 30, 2022	10,469,781	57	2,243	320	2,484	11,583,230	(79,970)	(1,093,310)	10,415,054	54,727
Balance at Mar. 31, 2022	8,543,106	54	1,887	275	2,024	9,347,732	(4,918)	(845,384)	8,501,670	41,436
Common stock issued	1,774,789	1	271	24	356	1,774,137			1,774,789
Offering costs	(71,148)					(71,148)			(71,148)
Distribution reinvestments	55,029	1	9	2	9	55,008			55,029
Amortization of restricted stock grants	207					207			207
Common stock repurchased	(118,271)		(9)		(33)	(118,229)			(118,271)
Net income (loss) (allocated to redeemable non-controlling interests)	(100,931)							(101,363)	(101,363)	432
Contributions from non-controlling interests	11,828									11,828
Distributions to non-controlling interests	(643)									(643)
Distributions declared on common stock (see Note 11)	(132,700)							(132,700)	(132,700)
Other comprehensive loss, net	(28,850)						(28,850)		(28,850)
Allocation to redeemable non-controlling interests	(18,119)					(18,119)			(18,119)
Balance at Jun. 30, 2022	9,914,297	56	2,158	301	2,356	10,969,588	(33,768)	(1,079,447)	9,861,244	53,053
Common stock issued	986,460	1	118	17	221	986,103			986,460
Offering costs	(26,783)					(26,783)			(26,783)
Distribution reinvestments	59,938		10	2	10	59,916			59,938
Amortization of restricted stock grants	206					206			206
Common stock repurchased	(402,360)		(43)		(103)	(402,214)			(402,360)
Net income (loss) (allocated to redeemable non-controlling interests)	130,065							128,675	128,675	1,390
Contributions from non-controlling interests	842									842
Distributions to non-controlling interests	(558)									(558)
Distributions declared on common stock (see Note 11)	(142,538)							(142,538)	(142,538)
Other comprehensive loss, net	(46,202)						(46,202)		(46,202)
Allocation to redeemable non-controlling interests	(3,586)					(3,586)			(3,586)
Balance at Sep. 30, 2022	$ 10,469,781	$ 57	$ 2,243	$ 320	$ 2,484	$ 11,583,230	$ (79,970)	$ (1,093,310)	$ 10,415,054	$ 54,727